These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3963840

  • 1. [Immunomodulation by antitumor antibiotics].
    Ishizuka M.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
    [Abstract] [Full Text] [Related]

  • 2. [Low molecular weight immunomodulators produced by microorganisms].
    Ishizuka M.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
    [Abstract] [Full Text] [Related]

  • 3. Aclacinomycin inhibits suppressor cells in vivo and in vitro.
    Orbach-Arbouys S, Andrade-Mena CE, Berardet M, Mathe G.
    Behring Inst Mitt; 1984 May; (74):258-61. PubMed ID: 6236791
    [Abstract] [Full Text] [Related]

  • 4. [New anthracycline antibiotics and derivatives].
    Tatsuta K.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [Abstract] [Full Text] [Related]

  • 5. [Effect of aclacinomycin B on DNA polymerase II of tumor cells].
    Li ZR, Feng JB, Han R, Yin MB, Xia LJ.
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):189-92. PubMed ID: 2943125
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR, Feng JB, Liang F, Zeng SX, Han R.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract] [Full Text] [Related]

  • 7. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [Abstract] [Full Text] [Related]

  • 8. [Spergualin, a new antitumor antibiotic].
    Takeuchi T.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [Abstract] [Full Text] [Related]

  • 9. Spergualin: a new antitumour antibiotic.
    Umezawa K, Takeuchi T.
    Biomed Pharmacother; 1987 Mar; 41(5):227-32. PubMed ID: 3499181
    [Abstract] [Full Text] [Related]

  • 10. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N.
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [Abstract] [Full Text] [Related]

  • 11. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
    Tanaka H, Yoshioka T, Shimauchi Y, Matsushita Y, Matsuzawa Y, Oki T, Inui T.
    J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
    [No Abstract] [Full Text] [Related]

  • 12. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
    Umezawa H.
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
    [Abstract] [Full Text] [Related]

  • 13. Mazethramycin, a new member of anthramycin group antibiotics.
    Kunimoto S, Masuda T, Kanbayashi N, Hamada M, Naganawa H, Miyamoto M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1980 Jun; 33(6):665-7. PubMed ID: 7419478
    [No Abstract] [Full Text] [Related]

  • 14. [Antitumor activity of macromomycin].
    Kato T, Yamanaka N, Katayama S, Mizutani M, Ota K.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
    [Abstract] [Full Text] [Related]

  • 15. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
    Ishizuka M, Masuda T, Mizutani S, Osono M, Kumagai H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
    [Abstract] [Full Text] [Related]

  • 16. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K, Kunimoto S, Takeuchi T.
    Biomed Pharmacother; 1987 Dec; 41(5):206-13. PubMed ID: 2444279
    [Abstract] [Full Text] [Related]

  • 17. Experimental pharmacology of auromomycin in L1210 tumor cells in vitro and in vivo.
    Samy TS, Siegel PJ, Hopper WE, Krishan A.
    Cancer Res; 1984 Aug; 44(8):3202-7. PubMed ID: 6589039
    [Abstract] [Full Text] [Related]

  • 18. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
    DuVernay VH, Essery JM, Doyle TW, Bradner WT, Crooke ST.
    Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S, Sasada M, Uchino H, Kagawa D, Ueda T, Nakamura T.
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec 20; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract] [Full Text] [Related]

  • 20. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
    Lu Y, Han J, Liu HY, Zhong GP, Yang S, Jia TZ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun 20; 8(3):211-3. PubMed ID: 2946461
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.